Manufactured Object
Hims eyes growth in its weight loss business, despite end of semaglutide shortage
semaglutide, weight loss business, United States Food and Drug Administration, Growth, Hims
Siemens Healthineers Expands U.S. Supply Chain with Strategic ‘Mega Depots’ to Combat Logistics Challenges
Siemens Healthineers, supply chain resilience, mega depots, logistics expansion, healthcare equipment, parts inventory, GXO partnership
Biotech Breakthroughs 2025: Emerging Trends and Technologies Shaping the Industry’s Future
CRISPR therapeutics, solid-state batteries, precision medicine, AI in drug discovery, gene editing, cancer vaccines, personalized therapies, biotech investment, platform technologies, clinical trial innovation
AI-Driven Enzyme Engineering: Baker Lab’s Latest Breakthrough in Computational Protein Design
AI-generated enzymes, computational protein design, artificial luciferases, de novo enzyme engineering, machine learning in biochemistry, Baker Lab, University of Washington
Pharma Ads Make Waves at Super Bowl 2025: Pfizer Wins Hearts, Hims & Hers Drives Engagement
Super Bowl 2025, pharmaceutical advertising, Pfizer, Hims & Hers, ad likeability, viewer engagement, healthcare marketing, cancer awareness, weight loss drugs
22 States Sue Trump Administration Over Drastic NIH Funding Cuts
NIH funding, indirect costs, research grants, Trump administration, lawsuit, universities, medical research
Bain Capital Acquires Mitsubishi Tanabe Pharma for $3.3 Billion in Strategic Japanese Pharma Investment
Bain Capital, Mitsubishi Tanabe Pharma, acquisition, Japanese pharmaceutical industry, carve-out transaction, private equity, life sciences investment
U.S. Hospitals Urge Trump to Exempt Medical Supplies and Pharmaceuticals from New Tariffs
Tariffs, medical supplies, pharmaceuticals, American Hospital Association, China, Mexico, Canada, healthcare costs, supply chain disruption, patient safety
Trump’s Tariffs Threaten to Disrupt Healthcare Supply Chain and Increase Costs
Trump tariffs, medical supply chain, healthcare costs, drug shortages, medical devices, pharmaceutical industry, import taxes
Charles River Laboratories Closing Durham Facility, Laying Off 31 Employees
Charles River Laboratories, Durham, North Carolina, facility closure, layoffs, pharmaceutical research, contract research organization, restructuring